Skip to main content
. 2023 Jun 14;70:56–62. doi: 10.1016/j.breast.2023.06.006

Table 2.

Prognostic factors for PFS in univariate and multivariate analysis.

Univariate Analysis HR (%95CI) p-value Multivariate Analysis HR (%95 CI) p- value
HER2-0 vs HER2 low 1.04 (0.69–1.56) 0.85
Ki67<%20 vs Ki67>%20 1.35 (0.86–2.11) 0.19
Grade 1–2 vs Grade 3 1.80 (1.12–2.88) 0.014 1.49 (0.92–2.41) 0.10
De novo vs recurren disease 0.68 (.46–1.01) 0.057
Visceral met vs non visceral met 3.20 (1.98–5.18) <0.001 2.70 (1.62–4.52) <0.001
First-line treatment vs subsequent lines treatment 0.50 (0.33–.74) 0.001 1.76 (1.10–2.82) 0.017
AI vs Fulvestrant 1.70 (1.16–2.51) 0.007 1.47 (0.92–2.33) 0.09

HR:hazard ratio, CI:confidence interval.